Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T18:31:24.697Z.
Consensus retrieved: 2026-10-06T11:34:12.962Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T18:31:24.697Z.
Quote observation: 2026-10-06T18:29:03.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1e37222dd90dbab5e03bfa1bbf20eaf6e61690ec1e62f49524765e66f30de265
Forward PE Ratio (N/A) = Dated Quote Price ($0.84) / Consensus Forward EPS ($-0.89)
FORWARD PE RATIO
N/A
Filana Therapeutics, Inc.
Market Cap
$40.49M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | $40.49M | N/A |
| Veru Inc. (VERU)vs › | $40.29M | N/A |
| Metagenomi, Inc. Common Stock (MGX)vs › | $39.15M | N/A |
| Precipio, Inc. (PRPO)vs › | $41.92M | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.81M | N/A |
| Nephros, Inc. (NEPH)vs › | $38.32M | 22.53 |
| Nano-X Imaging Ltd. (NNOX)vs › | $42.88M | N/A |
| Incannex Healthcare Limited (IXHL)vs › | $37.68M | N/A |
| BioStem Technologies, Inc. (BSEM)vs › | $43.56M | N/A |
| Rapid Micro Biosystems, Inc. (RPID)vs › | $43.70M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2026-12-31
At the dated quote price of $0.84, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $-0.90 | $-0.92 – $-0.87 | 2 | n/m |
| 2027-12-31 | $-1.19 | $-1.19 – $-1.19 | 1 | n/m |
| 2028-12-31 | $-1.18 | $-1.18 – $-1.18 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
